Abstract:Feline herpesvirus-1 (FHV-1) infection occurs worldwide and is a leading cause of respiratory and ocular diseases in cats. Current vaccines reduce the severity of symptoms but do not prevent infection and, therefore, do not provide defense against an establishment of latency and reactivation. We hypothesize that immunomodulation of FHV-1 is the cause of lack in protection and that deletion of virulence/immune modulatory genes of FHV-1 will enhance safety and immunogenicity. Our objective was to use feline respiratory epithelial cell (FREC) cultures to define in vitro growth characteristics and immunomodulation resulting from infection of FRECs with the virulent FHV-1 strain C27 (WT) and glycoprotein C-deletion (gC-), glycoprotein E-deletion (gE-), serine/threonine protein kinase-deletion (PK-), as well as gE and thymidine kinase-double-deletion (gE-TK-) mutants generated by bacterial artificial chromosome mutagenesis. Differentiated FRECs were mock inoculated or inoculated with WT, gC-, gE-, PK-, or gE-TK- mutants. Virus titration and real-time quantitative PCR assays were performed on samples collected at 1 hpi followed by 24 h intervals between 24 and 96 hpi to determine growth kinetics. Real-time PCR was used to quantitate IFNα, TNFα, IL-1β, IL-10, and TGFβ-specific mRNA levels. Immunoassays were performed to measure the protein levels of subsets of cytokines/chemokines secreted by FRECs. Inoculation of FRECs with gE-TK- resulted in significantly lower end-point titers than inoculation with WT or gE-. Both PK- and gC- inoculated FRECs also produced significantly lower end-point titers at 96 hpi than WT. Overall, intracellular virus titers were higher than those of extracellular virus. PCR results for viral DNA paralleled the virus titration results. Further, in contrast to WT inoculation, an increase in IFNα and IL-10 mRNA expression was not observed following inoculation with gE-TK- and PK-, but inoculation with gE-TK- and PK- did result in increased TGFβ expression in FRECs compared to responses following infection with WT. Moreover, gE-TK- and PK- blocked the inhibition of IL-8 and neutrophil chemoattractant (KC), which was observed following inoculation with WT. In summary, the results obtained in FRECs may be used to predict the safety and immunogenicity characteristics of these mutants in vivo. Our study highlights the value of the FREC system for studying replication kinetics/immune modulation factors of FHV-1 and screening prospective vaccine candidates before their use in experimental cats.

Establishment of Prokaryotic Expression System of Feline IFNω3-THYα1 Fusion Protein

Establishment of Prokaryotic Expression System of Porcine IFNα1-THYα1Fusion Protein

Cloning and Codon Optimization of a Novel Feline Interferon Omega Gene for Production by Pichia Pastoris and Its Antiviral Efficacy in Polyethylene Glycol-Modified Form

Cloning, Prokaryotic Soluble Expression, and Analysis of Antiviral Activity of Two Novel Feline IFN-ω Proteins.

Construction, Expression and Characterization of Human Interferon Α2b-（G4s）n-thymosin Α1 Fusion Proteins in Pichia Pastoris

Molecular Design and Characterization of Recombinant Fusion Protein of Human IFNα2a-THYα1

Prokaryotic-expressed porcine IFNα1-THYα1 fusion proteins exert IFN and THY activities in vitro

Enhancement of Mouse Immune Response by Recombinant Adenovirus Co-Expressing VP1-2A of Foot-and-mouth Disease Virus and Porcine IFN-α

Prokaryotic Expression of Porcine Type III Interferon and Studying on Its Antiviral Activity

Expression of Canine Interferon Α1 Gene in E.coli and Antiviral Activity of Expressed Product

Prokaryotic Expression of Fusion Gene of Cat Recombinant Allergen Fel d 1 with Hepatitis B Core Antigen

Fusion Expression of Immunological Epitopes from VP1-3 of Foot-and-mouth Disease Virus with Porcine Interferon-Gamma

Viral replication and innate immunity of feline herpesvirus-1 virulence-associated genes in feline respiratory epithelial cells

Expression and Bioactivities Study on IFN-IgG Fc Fusion Protein in Lactobacillus Casei

Fusion Expression and Preparation of Recombinant Human Interferon-β-1b

[Fusion Expression, Purification and Bioassay of IFN-gamma Inducible Protein-10 and Thioredoxin Gene in E. Coli].

An Efficient Expression System of Recombinant Human Interferon-α 2b in E. Coli

Expression of Bovine IFN-γ Gene and Preparation of Polyclonal Antibodies

PROKARYOTIC EXPRESSION AND ANTIVIRAL ANALYSIS OF CANINE INTERFERON α 2

Expression, Refolding, and Characterization of GFE Peptide-Fused Human Interferon-Α2a in Escherichia Coli

Stable expression of canine interferon alpha4 in CHO cells